Clinical trial
A Pivotal, Randomized, Subject- and Evaluator-blinded, Controlled, Non-inferiority, Multicenter, Parallel Group Comparison Study to Evaluate Effectiveness and Safety of THIODERM ELATE for Lip Augmentation in Order to Correct Lip Volume Deficit
NCT06133153 is registered in ClinicalTrials.gov with Croma-Pharma GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pivotal, Randomized, Subject- and Evaluator-blinded, Controlled, Non-inferiority, Multicenter, Parallel Group Comparison Study to Evaluate Effectiveness and Safety of THIODERM ELATE for Lip Augmentation in Order to Correct Lip Volume Deficit
- Lead sponsor
- Croma-Pharma GmbH
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- March 31, 2024
- Completion date
- April 30, 2026
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lip; anomaly